EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
Evogene Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$0.37−0.02 (-4.71%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 0.3
- Dividend yield
- –
Ownership
Who owns Evogene's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
3 buys · 0 sales
Net bought $695.08K
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Kfir Silberman | 3,057,488 | 19.35% | 13D (active) amendment | Sep 8, 2026 |
| L.I.A. Pure Capital Ltd. | 3,057,488 | 16.94% | 13D (active) amendment | Oct 6, 2026 |
| Ron Yair Peled | 3,057,488 | 19.35% | 13D (active) amendment | Aug 28, 2026 |
| Recanati Leon | 1,354,836 | 8.60% | 13D (active) amendment | Aug 4, 2026 |
| Armistice Capital, LLC | 1,104,906 | 9.99% | 13G (passive) | Mar 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ofer Haviv | President and CEO, Director | – | – | Mar 18, 2026 |
| Gabi Tarcic | Chief Development Officer | 1,129 | 0.01% | Aug 26, 2026 |
| Polina Ravzin | VP Finance | – | – | Apr 9, 2026 |
| Yaron Eldad | Chief Financial Officer | 4,100 | 0.05% | Mar 18, 2026 |
| Ilia Zhidkov | Chief Technology Officer | – | – | Mar 18, 2026 |
| Leon Recanati | Director | 1,343,886 | 15.41% | Sep 30, 2026 |
| Nir Nimrodi | Director | – | – | Sep 30, 2026 |
| Dan Michael Falk | Director | – | – | Sep 30, 2026 |
| Adrian John Percy | Director | – | – | Sep 30, 2026 |
| Sarit Firon | Director | – | – | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Leon Recanati Director | Aug 11, 2026 | Buy | +460,000 | $0.64 | $294.40K | 1,343,886 |
| Leon Recanati Director | Aug 4, 2026 | Buy | +800,000 | $0.50 | $400.00K | 883,886 |
| Gabi Tarcic Chief Development Officer | Jun 4, 2026 | Buy | +1,129 | $0.60 | $677 | 1,129 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.